BRAF and non-small cell lung carcinoma: Additional evidence for the role of RAF in dasatinib-induced senescence is that we previously demonstrated that transfection of KIBRAF into NSCLC cell lines increased their sentivity to dasatinib but when an additional mutation was added that prevented BRAF dimerization, no sensitization was observed [3].